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In Brief
Although transcription factors functional
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(PGCs), their PGC role remains unclear.
Here, Zhang et al. show that, without
Nanog, PGCs form ineffectively but that
normal PGC development can be
restored by induced expression of the
NANOG target gene Esrrb.
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https://doi.org/10.1016/j.celrep.2017.12.060SUMMARY
The transcription factors (TFs) Nanog and Esrrb
play important roles in embryonic stem cells (ESCs)
and during primordial germ-cell (PGC) development.
Esrrb is a positively regulated direct target of NANOG
in ESCs that can substitute qualitatively for Nanog
function in ESCs. Whether this functional substitu-
tion extends to the germline is unknown. Here, we
show that germline deletion of Nanog reduces PGC
numbers 5-fold at midgestation. Despite this quanti-
tative depletion, Nanog-null PGCs can complete
germline development in contrast to previous
findings. PGC-like cell (PGCLC) differentiation of
Nanog-null ESCs is also impaired, with Nanog-null
PGCLCs showing decreased proliferation and
increased apoptosis. However, induced expression
of Esrrb restores PGCLC numbers as efficiently as
Nanog. These effects are recapitulated in vivo:
knockin of Esrrb to Nanog restores PGC numbers
to wild-type levels and results in fertile adult mice.
These findings demonstrate that Esrrb can replace
Nanog function in germ cells.
INTRODUCTION
Naive pluripotency is established in epiblast cells of the mouse
blastocyst (Boroviak et al., 2014; Brook and Gardner, 1997).
The transcription factors (TFs) Oct4, Sox2, and Nanog are
required to establish epiblast identity and are fundamental plu-
ripotency regulators in vivo and in vitro (Festuccia et al., 2013).
Following implantation, the epiblast enters a transitional phase332 Cell Reports 22, 332–339, January 9, 2018 ª 2017 The Author(s)
This is an open access article under the CC BY license (http://creativein which cells remain uncommitted and functionally pluripotent
(Beddington, 1982; Osorno et al., 2012; Tam and Zhou, 1996).
At this point, expression of OCT4 and SOX2, but not NANOG
or other naive TFs, is maintained (Smith, 2017). Mouse primordial
germ cells (PGCs) are induced from the pluripotent post-implan-
tation epiblast early on embryonic day (E)6 (Ohinata et al., 2005)
and upregulate expression of many naive pluripotency genes
following specification (Kurimoto et al., 2008). PGCs do not
contribute to chimeras when injected into blastocysts (Leitch
et al., 2014), but possess a latent capacity to reacquire pluripo-
tency, which can be revealed in vivo during teratocarcinogenesis
(Stevens, 1983) or by the derivation in vitro of naive pluripotent
stem cell lines called embryonic germ cells (Leitch et al., 2013;
Matsui et al., 1992; Resnick et al., 1992). Furthermore, PGC
development is dependent on the expression of pluripotency
TFs. Conditional deletion of either Oct4 or Sox2 results in PGC
death (Campolo et al., 2013; Kehler et al., 2004). Nanog-null em-
bryonic stem cells (ESCs) exhibit broad differentiation potential,
including to migratory PGCs, but contribution to germ cells at
E12.5 was not observed in our previous study (Chambers
et al., 2007). Induced knockdown of Nanog in PGCs results in
significant alteration of their transcriptional program and subse-
quent apoptosis (Yamaguchi et al., 2009). Induction of PGC-like
cells (PGCLCs) in vitro is impaired in the absence of Nanog,
whereas exogenous Nanog improves PGCLC yield (Murakami
et al., 2016), in keeping with in vivo findings.
Nanog is essential for the specification of pluripotency in vivo
(Mitsui et al., 2003; Silva et al., 2009). However,Nanog-null ESCs
can be maintained, albeit with a reduced self-renewal efficiency
(Chambers et al., 2007). The orphan nuclear receptor Esrrb is a
regulator of ESC self-renewal (Festuccia et al., 2012; Ivanova
et al., 2006; Martello et al., 2012) and influences PGC numbers
in vivo (Mitsunaga et al., 2004). Esrrb is also a direct NANOG
target (Festuccia et al., 2012). Deletion of Esrrb abolishes the.
commons.org/licenses/by/4.0/).
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Figure 1. Conditional Deletion of Nanog
Reduces PGC Numbers
(A) Strategy for Nanog conditional knockout.
Nanogflox/flox females are crossed with Nanog+/;
Prdm1-Cre male mice. As Prdm1-Cre is hetero-
zygous, one in four embryos will have germline
deletion of Nanog (NanogD/).
(B) E11.5 genital ridge sections fromNanogD/ and
control embryos immunostained for Nanog, Dazl,
and GFP and counterstained with 4’,6-diamidino-
2-phenylindole (DAPI) (scale bar, 50 mm).
(C) Cell counts of PGCs in NanogD/ and control
genital ridges at E11.5. PGCs identified by co-
staining for Oct4 and either Dazl or Mvh. The mean
(± SD) of two biological and technical replicates for
each sample are shown. *p < 0.05 (unpaired Stu-
dent’s t test).
(D) E12.5 genital ridges from NanogD/ and control
embryos immunostained for GFP and Mvh and
counterstained with DAPI (scale bar, 50 mm).
(E) Table of breeding data for adultNanogD/mice.
Both male (row 2) and female (row 4 and 5)
NanogD/ mice are fertile.
See also Figure S1.ability of NANOG to confer leukemia inhibitory factor (LIF) inde-
pendence in ESCs (Festuccia et al., 2012). Furthermore, ESRRB
can compensate for NANOG function in epiblast stem cell
(EpiSC) reprogramming and in induced pluripotent stem cell
(iPSC) generation (Festuccia et al., 2012). Thus, Esrrb is a key
downstream mediator of Nanog function in the maintenance
and establishment of pluripotency in vitro. Here, we reassess
the requirement for Nanog in PGCs and investigate whether
ESRRB can compensate for NANOG function during PGC
development.
RESULTS
Conditional Deletion of Nanog Reduces PGC Numbers
To assess whether Nanog is required cell autonomously in
PGCs, a conditional knockout strategy was used. Mice homozy-
gous for a Nanog conditional allele (Nanogflox/flox) (Chambers
et al., 2007) were crossed with Nanog heterozygous miceCell(Nanog+/) (Mitsui et al., 2003) harboring
the Prdm1-Cre-BAC transgene (Ohinata
et al., 2005) (Figure 1A). One in four
offspring carried the Nanog null () and
conditionally deleted (D) alleles in PGCs.
As Prdm1-Cre-mediated excision has
been reported to be incomplete until after
E10.5 (Campolo et al., 2013; Kim et al.,
2014), genital ridges in control andmutant
embryos were dissected at E11.5
and analyzed by immunofluorescence.
NANOG protein was not detected in
mutant genital ridges (Figure 1B). How-
ever, GFP-positive cells were present,
indicating successful deletion of Nanog
(Figure 1B). GFP-positive cells werepositive for DAZL, indicating that these represent Nanog-null
PGCs (Figure 1B). Compared with littermate controls, PGC
numbers in Nanog mutant embryos were reduced 80% (Fig-
ure 1B and 1C). Surprisingly, a small number of GFP-positive
mutant PGCs expressing MVHwere also detected at E12.5 (Fig-
ure 1D). To establish whether these surviving Nanog mutant
PGCs were developmentally competent, subsequent litters
were allowed to go to term, and adult mutant mice of both sexes
were test-crossed (Figures S1A and S1B). Male and female
mutant mice were fertile (Figure 1E), passing either the knockout
or conditionally deleted allele to their offspring (Figure S1C).
These findings indicate that Prdm1-Cre-mediated deletion of
Nanog reduces the PGC number, but suggest that Nanog might
not be strictly required for germline development.
Nanog Is Not Essential for Germline Development
The requirement for Nanog in germline development was next
assessed using an alternative approach. First, Nanogflox/ ESCReports 22, 332–339, January 9, 2018 333
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Figure 2. Contribution of Nanog-Null ESCs to
Adult Chimeras, Including the Germline
(A) Strategy for generation NanogD/ (Nanog-null)
clonal ESC lines.
(B) Phase contrast and fluorescence images of
parental and Nanog-null ESC lines (scale bar,
100 mm).
(C) Oct4, Nanog, and GFP immunostaining of parental
and Nanog-null ESC lines (scale bar, 100 mm).
(D) Chimeras generated from Nanog-null ESCs,
C57BL/6 mates, and agouti and black pups. High-
contribution chimeras generated by injection of agouti
Nanog-null ESCs into C57BL/6 blastocysts.
(E) Summary of blastocyst injections and germline
contribution of four clonal Nanog-null ESC lines.
See also Figures S2 and S3.lines were derived from Nanogflox/flox 3 Nanog+/ intercrosses
(Figures S2A and S2B). Two independent clones were expanded
and exhibited normal ESC morphology (Figure S2C). Both lines
gave high contribution chimeras and germline transmission
(Figures S2D and S2E). Next, both Nanogflox/ ESC lines were
transiently transfected with Cre, and single GFP-positive cells
that had deleted Nanog were isolated (Figure 2A). Two GFP-
positive clones derived from each parental line were expanded
(Figure 2B). All four NanogD/ clones showed a higher differen-
tiation propensity than parental lines (Figure 2B), consistent
with abrogated Nanog function. Successful recombination
was confirmed by genomic PCR (Figure S3A). Nanog was un-
detectable by quantitative real-time PCR (Figure S3B) or immu-
nostaining (Figure 2C). NanogD/ lines were injected into
C57BL/6 blastocysts and three out of four clones produced
high contribution coat color chimeras (Figure 2D and 2E). On334 Cell Reports 22, 332–339, January 9, 2018test crossing, chimeras generated with two
independent clones (derived from different
parental lines) produced agouti pups, indi-
cating successful germline transmission.
This was confirmed by detection of either
the null or the deleted band in agouti
offspring (Figures 2E and S3D) and detec-
tion of GFP fluorescence from the recom-
bined allele in inner cell masses (ICMs)
from a further test cross (Figure S3C). These
results demonstrate clearly that Nanog func-
tion is not absolutely required for germline
development.
Esrrb Can Compensate for Nanog Loss
in PGCLCs In Vitro
Early PGC development can be recapitulated
in vitro by the induction of PGCLCs (Fig-
ure S4A) (Hayashi et al., 2011). Naive ESCs
in 2 inhibitors (2i)/LIF acquire competence
for PGCLC induction after 2 days of culture
in basic fibroblast growth factor (bFGF),
Activin A, and knockout serum replacement
(KSR) (Figures S4A, SD, and SE). Expression
of Prdm1 (also known as Blimp1) andPrdm14, accompanied by elevated levels of both Nanog and
Esrrb (Figure S4E) indicates PGCLC induction. In keeping with
recently published data (Murakami et al., 2016), Nanog-null
ESCs produced fewer PGCLCs than wild-type controls, as
measured by a decrease inCD61+/SSEA-1+ cells after day 4 (Fig-
ure 3A). Next, the doxycycline (Dox)-inducible system for gene
expression in Nanog-null cells (Festuccia et al., 2012) was as-
sessed for its ability to drive inducible transgene expression dur-
ing PGCLC differentiation (Figure S4B). The addition of Dox on
day 2 allowed robust expression of a tdTomato transgene (Fig-
ure S4C) without affecting PGCLC induction efficiency in either
wild-type or Nanog mutant ESCs (Figures 3A and S4D). The
same strategy induced expression of Nanog (Figures 3B and
S5A) and rescued the deficit in PGCLCs on day 6 and 8 to wild-
type levels (Figures 3A and 3B). ESRRB is a downstream medi-
ator of NANOG function in ESCs and during reprogramming
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C
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Figure 3. Esrrb Can Replace the Nanog
Requirement for Efficient PGCLC Differ-
entiation
(A) The proportion of SSEA1+/CD61+ cells during
PGC differentiation of E14TG2A and DN-itdT (left)
or DN-iNanog (DN-iN) and DN-iEsrrb (DN-iE) (right)
ESCs are shown at the indicated days of PGCLC
differentiation in the absence () or presence (+)
of Dox addition from day 2 onward (please
refer to Figure S5A for differentiation protocol
details). Values are means ± SDs; n = 3 biological
replicates.
(B and C) PGCLC differentiation of DN-iN (B) and
DN-iE (C) ESCs in the presence (+) or absence ()
of Dox. The morphology and Nanog:GFP expres-
sion of aggregates are shown (left; scale bar,
200 mm) with SSEA1/CD61 analysis by fluores-
cence-activated cell sorting (FACS) (right).
(D) Quantitative mRNA expression analysis during
PGC differentiation of DN-iN (left) and DN-iE (right)
in the presence (+) or absence () of Dox at the
indicated number of days of PGCLC differentia-
tion. Values are means ± SDs; n = 3 biological
replicates. *p < 0.05; **p < 0.01; and ***p < 0.001
(unpaired Student’s t test).
See also Figures S4–S6.(Festuccia et al., 2012). Deletion of Esrrb also reduces PGC
numbers in vivo (Mitsunaga et al., 2004). Interestingly, therefore,
Esrrb mRNA was detectable in E14Tg2a and Nanog/ cells at
day 2 of PGCLC differentiation (Figure S5B). This expression
increased during subsequent days of differentiation in wild-type
but not Nanog/ cells (Figure S5B). However, induction of
Nanog restored the increasing EsrrbmRNA levels during PGCLC
differentiation of Nanog/ cells (Figure S5B). These observa-
tions raise the hypothesis that ESRRB might also substitute for
NANOG in PGCLCs. Using the same strategy, induced expres-
sion of Esrrb (Figure S5C) also rescues the CD61/SSEA1 expres-
sion deficit to an equivalent degree toNanog (Figures 3A and3C).
PGCLCs rescued by either Nanog or Esrrb also express both
Prdm1 and Prdm14, confirming their identity (Figure 3D). Com-
pared with wild-type, Nanog/ PGCLCs showed an increasedCellproportion of active caspase-3-positive
cells, indicative of apoptosis (Figure S6A).
This was restored toward wild-type levels
by induction of either Nanog or Esrrb
(Figure S6A). Induction of either Nanog
or Esrrb also increased the staining
by anti-phospho-H3, suggestive of in-
creased proliferation (Figure S6B). These
results indicate that Esrrb can efficiently
rescue the deficit in PGCLCdifferentiation
observed in Nanog null ESCs.
Esrrb Can Compensate for Nanog
Loss in PGCs In Vivo
Having established that Esrrb can
compensate for Nanog loss in PGCLCs,
we next devised a strategy to assesswhether Esrrb might compensate for Nanog loss in
PGCs in vivo. First, ESCs were generated by homologous
recombination, in which Esrrb cDNA was expressed from the
endogenous Nanog locus at the Nanog AUG start codon
(designated Esrrb knockin [KI]) (Figure S7A). Correctly tar-
geted Nanog+/EsrrbKI ESCs were identified (Figure S7B). To
assess Esrrb mRNA expression in the Esrrb knockin model,
we analyzed Nanog/ ESCs carrying this Esrrb knockin allele.
This showed that Nanog/ ESCs express Esrrb mRNA at
60% of the wild-type level and that Nanog/EsrrbKI ESCs ex-
press Esrrb mRNA at 2-fold the level of wild-type ESCs (Fig-
ure S7C). Nanog+/EsrrbKI ESCs were used to establish mouse
lines by injection into blastocysts. Nanog+/EsrrbKI mice were
viable and fertile, with no obvious developmental defects
(unpublished data). The Prdm1-Cre-BAC transgene was thenReports 22, 332–339, January 9, 2018 335
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Figure 4. Esrrb Expression Can Rescue
Development of Nanog/ PGCs
(A) Schematic of Nanog conditional knockout,
Esrrb knockin strategy. Nanogflox/flox female mice
are crossed with Prdm1-Cre: Nanog+/EsrrbKI male
mice. As Prdm1-Cre is heterozygous, one in four
offspring will be Nanog conditional knockout,
Esrrb knockin (NanogD/EsrrbKI).
(B) E12.5 genital ridges from NanogD/EsrrbKI and
control embryos. GFP expression is from the
conditionally deleted (D) allele and is specific to
germ cells of the genital ridge (scale bar, 50 mm).
(C) Cell numbers were counted fromNanogD/EsrrbKI
and control genital ridges. PGCs are identified by
Dazl expression. The mean (± SD) of three bio-
logical replicates for control and NanogD/EsrrbKI are
shown. n.s., not significant.
(D) Table of breeding data for adult NanogD/EsrrbKI
and control mice. Both male (row 3) and female
(row 4) NanogD/EsrrbKI mice are fertile.
See also Figures S7 and S8.introduced and resulting mice crossed with the Nanogflox/flox
females (Figure 4A). In this case, one in four offspring would
carry both an EssrbKI and a Nanog conditional (flox)
allele in combination with a Prdm1-Cre-BAC transgene (Fig-
ure S8A). This combination, which is anticipated to result in
NanogD/EsrrbKI PGCs, was identified by genotyping somatic
tissue (Figure S8B). Immunofluorescence of genital ridges
from E12.5 NanogD/EsrrbKI embryos revealed equivalent
numbers of DAZL-positive PGCs compared with littermate
controls (Figures 4B and 4C). NANOG protein could not be
detected in NanogD/EsrrbKI PGCs, which were instead immuno-
reactive for GFP (Figure 4B). These results indicate that
expression of Esrrb under the control of Nanog regulatory el-
ements can rescue development of Nanog-null PGCs. Further-
more, NanogD/EsrrbKI PGCs are fully competent to complete
germline development, as both male and female of this geno-
type were fertile (Figures 4D and S8C). Taken together, these336 Cell Reports 22, 332–339, January 9, 2018observations both in vitro and in vivo
suggest that Esrrb can substitute for
Nanog function in germ cells.
DISCUSSION
Although conditional knockout ap-
proaches have shown that the Oct4 and
Sox2 are essential for PGC development
(Campolo et al., 2013; Kehler et al.,
2004), studies on other pluripotency TFs
have proved challenging. Here, we use
conditional knockout strategies, mouse
chimeras, and the recently developed
PGCLC system (Hayashi et al., 2011) to
assess the function of the Nanog-Esrrb
axis in PGCs. This study establishes a
role for Nanog in regulating PGC numbers
in vivo. However, as for ESCs (Chambers
et al., 2007), Nanog is strictly dispensablefor PGC function. We show that knockin of Esrrb to theNanog lo-
cus can complement the Nanog defect and is sufficient to rescue
PGC numbers in vivo. Our study also supports a recently pro-
posed role for Nanog in themaintenance of PGCLCs from plurip-
otent stem cells in vitro (Murakami et al., 2016), but expands on
these findings, establishing that Esrrb can substitute for Nanog
function in this system. Therefore, in addition to ESC self-renewal
and iPSC reprogramming, Esrrb can functionally substitute for
Nanog in PGC development. This strengthens the hypothesis
that aspects of the naive pluripotency network are re-established
in PGCs (Leitch andSmith, 2013). It will therefore be interesting to
seewhether the recently reportedmitotic bookmarking activity of
Esrrb in ESCs is also conserved in PGCs (Festuccia et al., 2016).
Previous experiments have suggested that Nanog is required
for PGC development (Chambers et al., 2007; Yamaguchi et al.,
2009). Although chimera experiments showed that Nanog/
ESCs could form nascent PGCs at E11.5, Nanog-null PGCs
were not observed one day later at E12.5 (Chambers et al.,
2007). This loss of PGCs was shown to be due to Nanog muta-
tion, since repair of Nanog by homologous recombination
restored E12.5 PGCs (Chambers et al., 2007). These findings
were largely supported by a study in which induced knockdown
of Nanog led to PGC death (Yamaguchi et al., 2009). More
recently, however, Nanog/ iPSCs were reported to be
capable of germline transmission based on expression of a
GFP transgene in tissues of chimera-derived offspring (Carter
et al., 2014). Our present findings provide unequivocal evidence
that PGC development can be completed in the absence of
Nanog by showing that two newly derived Nanog/ ESC lines
exhibit germline transmission, as judged by coat color and the
presence of Nanog-null alleles in F1 pups. Together with the se-
vere reduction in PGC numbers observed in our conditional
deletion experiments, this clarifies that the absence of NANOG
compromises the development of the PGC population, but
that individual PGCs can acquire full functionality in the absence
of NANOG. This germline phenotype may render Nanog/
PGCs disadvantaged compared with wild-type PGCs in the
context of chimeras and reduce the frequency with which germ-
line competency is observed. Our previous Nanog-null chimera
experiments were performed using ESCs cultured in LIF/fetal
calf serum (FCS). In contrast, both current examples of germline
transmission were obtained using cells cultured in 2i/LIF,
which may have enhanced the degree of chimerism, thereby
increasing the likelihood of observing germline transmission,
as previously shown for 3i/LIF culture medium (Kiyonari et al.,
2010).
The fact that Esrrb can substitute for Nanog provides func-
tional evidence that the naive pluripotency network may be
conserved in PGCs. It is of interest that Esrrb fully restored
PGC numbers by E12.5 when expressed fromNanog. Tetraploid
embryos complemented by morula aggregation with Esrrb-null
ESCs showed a reduction in PGC numbers of 50%–80% be-
tween E13.5 and E15.5 (Mitsunaga et al., 2004). Esrrb transcripts
were first detected by real-time (RT)-PCR at E11.5 (Mitsunaga
et al., 2004), with Nanog expression detected earlier in PGCs
(Yamaguchi et al., 2005). However, re-analysis of published sin-
gle-cell RNA sequencing (RNA-seq) data from PGCs (Hackett
et al., 2013; Magnu´sdo´ttir et al., 2013) shows that Esrrb and
NanogmRNAs both increase in expression from E6.5 to E7.5, re-
maining relatively steady thereafter until E12.5 (Figure S9). This
suggests that ESRRB may function in PGCs before E11.5. Esrrb
is also expressed during PGCLC differentiation, but at a reduced
level in Nanog/ PGCLCs relative to wild-type cells. The wild-
type expression level of Esrrb mRNA is restored in Nanog/
PGCLCs by Nanog induction. These results indicate that
NANOG controls Esrrb expression in PGCs, but that, as is the
case in ESCs, positive inputs in addition to NANOG also
contribute to Esrrb expression (Festuccia et al., 2012; Martello
et al., 2012).
Nanog/ cells undergoing PGCLC differentiation showed
increased apoptosis and reduced proliferation, validating previ-
ous important observations using an in vivo conditional knock-
down approach (Yamaguchi et al., 2009). Consistent with this
seminal study, apoptotic cells positive for active caspase-3
were invariably either OCT4 low or OCT4 negative. Restoringeither Nanog or Esrrb expression in Nanog/ PGCLCs is suffi-
cient to reverse both the apoptosis and proliferation defects.
Together, these studies add to the evidence that Esrrb is a
physiologically relevant mediator of PGCLC function (Mitsunaga
et al., 2004).
A limited number of studies have focused on other naive plu-
ripotency factors in the germline. In addition to Oct4 and Sox2,
conditional knockout of Sall4 in PGCs does appear to affect
gonadal PGC numbers, although interpretation is complicated
by the mosaic deletion brought about by TNAP-Cre (Yamaguchi
et al., 2015). The extent to which other pluripotency factors influ-
ence germline competence, PGC specification, and subsequent
development is of significant interest. The PGCLC system may
be an ideal tool to assess these factors. Recently, it was reported
that induced expression of Nanog is sufficient to induce
PGCLCs from epiblast-like cells (EpiLCs) (Murakami et al.,
2016). Together with our data, this may indicate that Nanog
has a dose-dependent influence on both the specification and
maintenance of PGCs. This is reminiscent of the role of Nanog
in ESCs, in which Nanog is not absolutely required, but functions
as a pluripotency rheostat (Chambers et al., 2007; Mullin et al.,
2017; 2008). In this regard, it is notable that Prdm14 is a direct
Nanog responsive gene in ESCs (Festuccia et al., 2012; 2013)
and responds to Nanog in EpiLCs (Murakami et al., 2016). The
ability of Esrrb to restore function in vitro to Nanog/ PGCLCs
further underscores the similarities between naive pluripotency
and germline development. It would be interesting to assess
whether elevated levels of Nanog or Esrrb in vivomight enhance
PGC specification and germ cell numbers. How such manipula-
tions of the pluripotency gene regulatory network might affect
PGC identity is also of interest. This will enable us to reveal
how the pluripotency gene regulatory network interacts with
germ-cell-specific genes during PGC development and so build
on the remarkably insightful studies that first pioneered the
connection between pluripotency and the germline more than
half a century ago (Stevens, 1983).
EXPERIMENTAL PROCEDURES
Animal studies were authorized by a UK Home Office Project License and
carried out in a Home-Office-designated facility.
PGCLC Differentiation
PGCLC differentiation was performed essentially as described previously
(Hayashi et al., 2011). Briefly, ESCs were cultured in 2i/LIF medium (as above)
for several passages. Cells were then seeded onto fibronectin-coated plates at
13 105 cells/12 well in N2B27/1%KSR/bFGF/Activin A to obtain EpiLCs. Two
days later, EpiLCswere collected and aggregated at 2,000 cells/well in PGCLC
medium (50 ng/mL bone morphogenetic protein (BMP)4, 50 ng/mL BMP8a,
10 ng/mL stem cell factor [SCF], 10 ng/mL epidermal growth factor [EGF],
and 1,000 U/mL LIF) using U-bottom 96-well plates (Thermo Fisher Scientific,
174925). For induction of gene expression, 1 mg/mL Dox (Sigma, D9891) was
added at day 2 of PGCLC differentiation.
Further methods can be found in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
nine figures, and two tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.12.060.Cell Reports 22, 332–339, January 9, 2018 337
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